NRP-1, involved in cell survival and proliferation, seems to favor an undifferentiated phenotype in cancer cells [33] and its overexpression has been reported to be correlated with a poor prognosis in both GBM [34] and MB [35]. Here, NRP1 is linked to glioblastoma.